Compliance with eye care in glaucoma patients with comorbid depression

Israel Medical Association Journal

Volumn 13, Issue 12, 2011, Pages 730-733

  Weiss, Guy A ^a   Goldich, Yakov ^b,d   Bartov, Elisha ^c,d   Burgansky Eliash, Zvia ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Compliance with glaucoma therapy; Depression; Glaucoma; Glaucoma medical therapy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; PROSTAGLANDIN DERIVATIVE; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; EYE CARE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PERIMETRY; PREVALENCE; QUESTIONNAIRE; SCREENING; CHRONIC DISEASE; DISEASE COURSE; DRUG EFFECT; DRUG INSTILLATION; INTRAOCULAR PRESSURE; LONG TERM CARE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; STATISTICS; VISION TEST;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; DISEASE PROGRESSION; FEMALE; GLAUCOMA; HUMANS; INSTILLATION, DRUG; INTRAOCULAR PRESSURE; ISRAEL; LONG-TERM CARE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREVALENCE; QUESTIONNAIRES; VISION TESTS;

EID: 84858046325     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Quigley HA, Broman AT. The number of people 1. with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-267.
2. Avisar R, Friling R, Snir M, Avisar I, Weinberger D. Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003. IMAJ Isr Med Assoc J 2006; 8: 880-881.
3. Lee MD, Fechtner FR, Fiscella RG, Singh K, Stewart WC. Emerging perspectives on glaucoma: highlights of a roundtable discussion. Am J Ophthalmol 2000; 130: S1-11.
4. Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: adherence by the elderly. Am J Public Health 1993; 83: 711-716.
5. Hollo G, Kothy P, Anna G, Vargha P. Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma. J Glaucoma 2009; 18: 288-292.
6. Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther 2002; 18: 401-409.
7. Harpole LH, Williams JW Jr, Olsen MK, et al. Improving depression outcomes in older adults with comorbid medical illness. Gen Hosp Psychiatry 2005; 27: 4-12.
8. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-497.
9. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment - meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-1207.
10. Yun LWH, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005; 38: 432-438.
11. Jayawant SS, Bhosle MJ, Anderson RT, Balkrishnan R. Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma. J Glaucoma 2007; 16: 513-520.
12. Pappa C, Hyphantis T, Pappa S, et al. Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment. J Psychosom Res 2006; 61: 609-617.
13. Wilson MR, Coleman AL, Yu F, Sasaki IF, Bing EG, Kim MH. Depression in patients with glaucoma as measured by self-report surveys. Ophthalmology 2002; 109: 1018-1022.
14. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994; 10: 77-84.
15. Friedman DS, Okeke CO, Jampel HD, et al. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology 2009; 116: 1097-105.
16. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74.
17. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009; 15: 59-66.
18. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10: 348-354.
19. Krousel-Wood M, Muntner P, Jannu A, Desalvo K, Re RN. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci 2005; 330: 128-133.
20. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol 1986; 101: 524-530.
21. Shi L, Liu J, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics 2010; 28: 1097-1107.
22. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005; 140: 598-606.
23. Kaiserman I, Kaiserman N, Elhayany A, Vinker S. Topical beta-blockers are not associated with an increased risk of treatment for depression. Ophthalmology 2006; 113: 1077-1080.
24. Geulayov G, Lipsitz J, Sabar R, Gross R. Depression in primary care in Israel. IMAJ Isr Med Assoc J 2007; 9: 571-578.
25. Iancu I, Horesh N, Lepkifker E, Drory Y. An epidemiological study of depressive symptomatology among Israeli adults: prevalence of depressive symptoms and demographic risk factors. Isr J Psychiatry Relat Sci 2003; 40: 82-89.